Lercanidipine in Patients with Chronic Renal Failure: The ZAFRA Study

References

• Klag, M J.; Whelton, P K.; Randall, B L.; Neaton, J D.; Brancati, F L.; Ford, C E.; Shulman, N B.; Stamler, J. Blood pressure and end-stage renal disease in men. N. Engl. J. Med. 1996, 334, 13–18. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rostand, S G.; Brunzell, J D.; Cannon, R O.; Victor, R G. Cardiovascular complications in renal failure. J. Am. Soc. Nephrol. 1991, 2, 1053–1058. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shulman, N B.; Ford, C E.; Hall, W D.; Blaufox, M D.; Simon, D.; Langford, H G.; Schneider, K A. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The hypertension detection and follow-up program cooperative group. Hypertension 1989, 13 (Suppl 5), I180–I193.
   Google Scholar
• Samuelsson, O.; Wilhelmsen, L.; Elmfeldt, D.; Pennert, K.; Wedel, H.; Wikstrand, J.; Pennert, K.; Wedel, H.; Wikstrand, J.; Berglund, G. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. J. Hypertens. 1985, 3, 167–176. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ruilope, L M.; Campo, C.; Rodriguez-Artalejo, F.; Lahera, V.; Garcia-Robles, R.; Rodicio, J L. Blood pressure and renal function: therapeutic implications. J. Hypertens. 1996, 14, 1259–1263. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mandhavan, S.; Stockwell, D.; Cohen, H.; Alderman, M H. Renal function during antihypertensive treatment. Lancet 1995, 345, 749–751. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Barrios, V.; Navarro, A.; Esteras, A.; Luque, M.; Romero, J.; Tamargo, J.; Prieto, L.; Carrasco, J L.; Herranz, I.; Navarro-Cid, J.; Ruilope, L M. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE study. Blood Pressure 2002, 11, 95–100. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leonetti, G.; Magnani, B.; Pessina, A C.; Rappelli, A.; Trimarco, B.; Zanchetti, A.; COHORT Study Group. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am. J. Hypertens. 2002, 15, 932–940. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• DiGiorgio, L A.; Orlandini, F.; Malasoma, P.; Zappa, A. A double-blind cross-over study of lercanidipine versus amlodipine in the treatment of mild-to-moderate essential hypertension. Curr. Ther. Res. 1999, 60, 511–520. [CROSSREF]
   Google Scholar
• Tobbe, S.; Epstein, M. The use of calcium antagonists in the treatment of hypertensive persons with kidney disease. Curr. Hypertens. Rep. 2002, 4, 191–194. [CSA]
   PubMedGoogle Scholar
• Bitar, R.; Flores, O.; Reverte, M.; Lopez-Novoa, J M.; Macias, J F. Beneficial effect of verapamil added to chronic ACE inhibitor treatment on renal function in hypertensive elderly patients. Int. Urol. Nephrol. 2000, 32 (2), 165–169., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Messerli, F H. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am. J. Hypertens. 2002, 15 (Pt2), 94S–97S. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Neal, B.; MacMahon, S.; Chapman, N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Blood pressure lowering treatment trialists' collaboration. Lancet 2000, 356, 1955–1964. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Opie, L H.; Schall, R. Evidence-based evaluation of calcium channel blocker for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy. J. Am. Coll. Cardiol. 2002, 39, 315–322. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lewis, E.; Huncksicker, L G.; Clarke, W R.; Berl, T.; Pons, M A.; Lewis, J B.; Ritz, E.; Atkins, R C.; Rohde, R. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 2001, 345, 851–860. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rengo, F.; Romis, L. Activity of lercanidipine in double-blind comparison with nitrendipine in combination treatment of patients with resistant essential hypertension. J. Cardiovasc. Pharmacol. 1997, 29 (Suppl. 2), S54–S58.
   Google Scholar
• Morisco, C.; Trimarco, B. Efficacy and tolerability of lercanidipine in comparison to and in combination with atenolol in patients with mild to moderate essential hypertension in a double blind controlled study. J. Cardiovasc. Pharmacol. 1997, 29 (Suppl. 2), S54–S58.
   Google Scholar
• Barbagallo, M.; Barbagallo, G. Sangiorgi, Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension. Aging Clin. Exp. Res. 2000, 12, 375–379. [CSA]
   Google Scholar
• Messerli, F H. Vasodilatory edema: a common side effect of antihypertensive therapy. Am. J. Hypertens. 2001, 14, 978–979. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hanson, L.; Lindholm, L H.; Ekbom, T.; Dahlöf, B.; Lanke, J.; Schersten, B.; Wester, P.-O.; Hedner, T.; d Faire, U.; STOP-Hypertension-2 study group, Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. The Swedish trial in old patients with hypertension-2 study. Lancet 1999, 354, 1751–1756. [CROSSREF]
   PubMedGoogle Scholar
• Messerli, F H.; Oparil, S.; Feng, Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonists (either nifedipine or amlodipine) versus high-dose calcium antagonists monotherapy for systemic hypertension. Am. J. Cardiol. 2000, 86, 1182–1187. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Parving, H H. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy. J. Hypertens. 1990, 8, S187–S191.
   Google Scholar
• Peterson, J C.; Adler, S.; Burkart, J M.; Greene, T.; Hebert, L A.; Hunsicker, L G.; King, A.; Klahr, S.; Massry, S G.; Seifter, J L. Blood pressure control, proteinuria and the progression of renal disease: the modification of diet in renal disease study. Ann. Intern. Med. 1995, 123, 754–762. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Toto, R D.; Mitchell, N C.; Smith, R D. “Strict” blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int. 1995, 48, 851–859. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Gansevoort, R T.; Sluiter, W J.; Hemmelder, M H.; de Zeeuw, D.; de Jong, P E. Antiproteinuric effect of blood pressure lowering agents: a meta-analysis of comparative trials. Nephrol. Dial. Transplant. 1995, 10, 1963–1974. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Maki, D D.; Ma, J Z.; Louis, T A.; Kasiske, B L. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch. Intern. Med. 1995, 155, 1073–1080. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Weidmann, P.; Schneider, M.; Bohlen, L. Therapeutic efficacy of different anti-hypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol. Dial. Transplant. 1995, 10 (Suppl. 9), 39–45. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease, 1995 Update of the working group reports on chronic renal failure and renovascular hypertension. Arch. Intern. Med. 1996, 156, 1938–1947. [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Brenner, B M.; Cooper, M E.; de Zeeuw, D.; Keane, W F.; Mitch, W E.; Parving, H H.; Remuzzi, G.; Snappin, S M.; Zhang, Z.; Shahinfar, S. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001, 345, 861–869. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Parving, H H.; Lehnert, H.; Bröchner-Mortensen, J.; Gomis, R.; Andersen, S.; Arner, P. For the study group Irbesartan in patients with type 2 diabetes and microalbuminuria. N. Engl. J. Med. 2001, 345, 870–878. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kesteloot, H.; Joossens, J V. On the determinants of the creatinine clearance: a population study. J. Hum. Hypertens. 1996, 10, 245–249. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lemann, J.; Bidani, A.; Bain, R P.; Lewis, E.; Rohde, R D.; Collaborative Study Group, Use of serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Am. J. Kidney Dis. 1990, 16, 236–243., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Voyaki, S M.; Staessen, J A.; Thijs, L.; Wang, J G.; Efstratopoulos, A D.; Birkenhäger, W H.; de Leeuw, P W.; Leonetti, G.; Nachev, C.; Rodicio, J L.; Tuomilehto, J.; Fagard, R.; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators, Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. J. Hypertens. 2001, 19, 511–519. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bakris, G L.; Mangrum, A.; Copley, J B.; Vicknair, N.; Sadler, R. Effect of calcium channel or ß-blockade on the progression of diabetic nephropathy in African Americans. Hypertension 1997, 29, 744–750. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Brown, M J.; Palmer, C R.; Castaigne, A.; de Leeuw, P W.; Mancia, G.; Rosenthal, T.; Ruilope, L M. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the international nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT). Lancet 2000, 356, 366–372. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Agodoa, L Y.; Appel, L.; Bakris, G L.; Beck, G.; Bourgoignie, J.; Brigs, J P.; Charlestown, J.; Cheek, D.; Cleaveland, W.; Douglas, J G.; Douglas, M.; Dowie, D.; Faulkner, M.; Gabriel, A.; Gassman, J.; Greene, T.; Hall, Y.; Hebert, L.; Hiremath, L.; Jamerson, K.; Johnson, C J.; Kopple, J.; Kusek, J.; Lash, J.; Lea, J.; Lewis, J B.; Lip Kowitz, M.; Massry, S.; Middleton, J.; Miller, E R., III.; Norris, K.; O'Conner, D.; Ojo, A.; Phillips, R A.; Pogue, V.; Rahman, M.; Randall, O S.; Rostand, S.; Schulmar, G.; Smith, W.; Thornley-Brown, D.; Tisher, C C.; Toto, R D.; Wright, J T., Jr.; Xu, S. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001, 285, 2719–2728. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Epstein, M. Calcium antagonists and renal protection: emerging perspectives. J. Hypertens. 1998, 18 (Suppl. 4), S17–S25.
   Google Scholar
• Sabbatini, M.; Leonardi, A.; Testa, R.; Vitaioli, L.; Amenta, F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000, 35, 775–779. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schultz, P.; Raij, L. Inhibition of human mesangial cell proliferation by calcium channel blockers. Hypertension 1990, 15 (Suppl. 1), 76–80.
   Google Scholar
• Hebert, L A.; Bain, R P.; Verme, D.; Cattran, D.; Whittier, F C.; Tolchin, N.; Rohde, R D.; Lewis, E J.; Collaborative Study Group, Remission of nephrotic range proteinuria in type I diabetes. Kidney Int. 1994, 46, 1688–1693. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Bakris, G L.; Williams, B. ACE inhibitors and calcium antagonists alone or combined: is there a difference on progression of diabetic renal disease?. J. Hypertens. 1995, 13 (suppl 2), S95–S101. [CSA]
   Google Scholar
• Bakris, G L.; Weir, M R.; DeQuattro, V.; McMahon, F G. Effects of an ACE inhibitor/calcium antagonists combination on proteinuria in diabetic nephropathy. Kidney Int. 1998, 54, 1283–1289. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• The effects of an ACE inhibitor and a calcium antagonists on the progression of renal disease: the nephross study. Nephrol. Dial. Transplant. 2001, 16, 2158–2166. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar